Biotech

All Articles

Metsera coordinate with Amneal to secure down GLP-1 source

.Along with early stage 1 information right now out in the wild, metabolic health condition ensemble...

Rivus posts records to back up muscle-sparing excessive weight drug cases

.Rivus Pharmaceuticals has revealed the records behind its own period 2 being overweight gain in car...

BMS spends $110M to form T-cell treatment deal, assisting Main purchase time to improve prioritized pipe

.Bristol Myers Squibb is actually paying for Perfect Medicine $110 million in advance to cultivate r...

Generate increases yet another $1B-plus Huge Pharma relationship

.Novartis has actually inked a deal likely worth more than $1 billion with Flagship-founded Generate...

Metsera GLP-1 information cut uncovers 7.5% weight-loss at 36 times

.Recently debuted Metsera is unfolding some phase 1 data for its own GLP-1 receptor agonist, exposin...

Flagship really hopes biotechs flock to Mirai to boost genetic meds

.Among the hereditary medications arms ethnicity, Flagship Pioneering is revealing a brand-new firm ...

BioAge eyes $180M from IPO, private positioning for obesity trials

.BioAge Labs is actually eyeing about $180 thousand in preliminary earnings from an IPO and also a p...

Merck's LAG-3 combo fails colorectal cancer phase 3 research study

.An effort by Merck &amp Co. to uncover the microsatellite steady (MSS) metastatic colon cancer cell...

Spanish VC finalizes $200M lifestyle sciences fund

.Spain-based Asabys Allies has actually finalized a fund of 180 thousand euros ($ 200 thousand), mon...

BioAge brings in $198M coming from IPO as obesity biotech joins Nasdaq

.BioAge Labs is bringing in almost $200 million through its Nasdaq IPO this morning, with the procee...